Invention Grant
- Patent Title: Controlled release dosage form with enhanced pharmacokinetics
-
Application No.: US16178865Application Date: 2018-11-02
-
Publication No.: US10532031B2Publication Date: 2020-01-14
- Inventor: Glenn A. Meyer , Cristian R. Franco , Gustavo A. Fischbein , Claude E. Wright
- Applicant: OSMOTICA KERESKEDELMI ES SZOLGALTATO KFT
- Applicant Address: HU Budapest
- Assignee: OSMOTICA KERESKEDELMI ES SZOLGALTATO KFT
- Current Assignee: OSMOTICA KERESKEDELMI ES SZOLGALTATO KFT
- Current Assignee Address: HU Budapest
- Agency: Innovar, L.L.C.
- Agent Rick Matos
- Main IPC: A61K9/28
- IPC: A61K9/28 ; A61K9/20 ; A61K31/197 ; A61K9/00 ; A61K9/14 ; A61K31/325
Abstract:
The present invention provides a simple and improved dosage form that is capable of providing a controlled release of GABAB receptor agonist contained in the core thereof. The invention also provides methods of administering the dosage form and of treating conditions that are therapeutically responsive to GABAB receptor agonist.
Public/Granted literature
- US20190070121A1 Controlled Release Dosage Form with Enhanced Pharmacokinetics Public/Granted day:2019-03-07
Information query
